Sign In
Buy TBIO
$0.0530
+0 (+0%)
At Close: Jun 03, 2026
Telesis Bio Reports Second Quarter 2023 Financial Results
04:05pm, Thursday, 10'th Aug 2023
-- Total revenue of $8.7M in 2QFY23 - increased by 53% year over year -- Total revenue of $8.7M in 2QFY23 - increased by 53% year over year
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
05:00pm, Thursday, 03'rd Aug 2023
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its second quarter 2023
Telesis Bio to Present at Jefferies Healthcare Conference 2023
09:05am, Thursday, 08'th Jun 2023
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder of
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
03:00am, Tuesday, 06'th Jun 2023
Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery
Telesis Bio to Present at SynBioBeta 2023
09:00am, Tuesday, 23'rd May 2023
Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery Highlighting application of the Molecular Biology Workstation to accelerating vaccine and
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
09:00am, Monday, 15'th May 2023
Showcasing Automated Molecular Biology Workstation for Synthetic Biology and Genomics Applications Showcasing Automated Molecular Biology Workstation for Synthetic Biology and Genomics Applications
Telesis Bio (TBIO) Reports Q1 Loss, Misses Revenue Estimates
07:02pm, Thursday, 11'th May 2023
Telesis Bio (TBIO) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.45 per share a year ago.
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
04:05pm, Thursday, 27'th Apr 2023
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its first quarter 2023
